Are You in Control of Your Data

Innovative Biosensors, Inc. Raises $3.5 Million Funding

Innovative Biosensors, Inc (IBI), a company developing rapid, ultra-sensitive tests to detect pathogens, have raised $3.5 Million in Series A financing led by Harbert Venture Partners, LLC. Other investors include New Markets Growth Fund and the Maryland Venture Fund.

Founded in mid 2003, IBI licensed the CANARY ™ technology from MIT in August 2003. The technology enables the detection of pathogens with an unprecedented combination of speed and sensitivity. The company recently launched its E. coli O157:H7 Detection Kit for food processors and plans to introduce more tests in the food testing and human clinical diagnostics markets.


NOTE: This item is from our 'historic' database and may contain information which is not up to date.

Source: Innovative Biosensors, Inc View archived contact details

Posted: June 6, 2005
Request Information
[will open your email client]

© 2001 - 2017 Rapid Test Methods Ltd • Please join us on Twitter, Facebook and LinkedIn • RSS Feed